Skip to main content
. 2014 May 6;55(5):2993–3002. doi: 10.1167/iovs.13-12660

Figure 1.

Figure 1

Study flow diagram. *One patient was randomized to receive difluprednate 0.05% and was treated with prednisolone acetate 1%. This individual was included in the intent-to-treat population as randomized (difluprednate) and in the safety population as treated (prednisolone acetate) and was excluded from the per-protocol population.